For example, the systemic delivery of a vaccinia OV armed with a CXCR4 antagonist to mice with orthotopic mammary tumours disrupted the interaction between tumour cell CXCR4 and CXCL-12 present in the stromal microenvironment. Here, CXCR4 is linked to neoplasm.